Menu Search
Equities

MERCK DRN

MRCK34:SAO

MERCK DRN

Actions
  • Price (BRL)87.56
  • Today's Change-0.55 / -0.62%
  • Shares traded2.16k
  • 1 Year change+32.67%
  • Beta--
Data delayed at least 15 minutes, as of Jul 22 2024 20:53 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MRK:NYQ since
announced		Transaction
value
Caraway Therapeutics IncAnnounced21 Nov 202321 Nov 2023Announced22.34%610.00m
Data delayed at least 15 minutes, as of Jul 22 2024 20:53 BST.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Caixa DTVM SAas of 31 Mar 2024292.83k0.00%
Banco J. Safra SAas of 31 Mar 2024138.41k0.00%
Bram Bradesco Asset Management S/A DTVMas of 31 Mar 202441.13k0.00%
Safra Asset Management Ltda.as of 31 Mar 202437.90k0.00%
XP Allocation Asset Management Ltda.as of 31 Mar 20242.69k0.00%
BB Gest�o de Recursos DTVM SAas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 18 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.